Confluent (CFLT) shares rose about 20% in recent Wednesday trading after several analysts raised their price targets on the stock following the company's forecast-beating Q4 results.
RBC Capital Markets increased its price target on Confluent to $41 from $36 while keeping its outperform rating.
"Confluent reported strong results with all key metrics
ahead of expectations and the high-end of guidance," RBC said in a note. "We feel Confluent is well-positioned for share gains and remains a top SMID-cap idea."
Other price target increases were from Truist to $40 from $35, Oppenheimer to $40 from $37, and UBS to $34 from $26.
Price: 35.99, Change: +5.89, Percent Change: +19.57
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.